Insider · CIK 0001385155

Meeker David P

Reports to the SEC for 9 companies · BOSTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001385155

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-14	RYTMRHYTHM PHARMACEUTICALS, INC. · Employee Stock Option (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−50K sh	—	—	15,431
2026-09-14	RYTMRHYTHM PHARMACEUTICALS, INC.S Sale	Director, President and CEO	SSale	−6,439 sh	$101.75	−$655K	282,819
2026-09-14	RYTMRHYTHM PHARMACEUTICALS, INC.S Sale	Director, President and CEO	SSale	−2,300 sh	$105.19	−$242K	239,258
2026-09-14	RYTMRHYTHM PHARMACEUTICALS, INC.S Sale	Director, President and CEO	SSale	−8,698 sh	$103.43	−$900K	243,375
2026-09-14	RYTMRHYTHM PHARMACEUTICALS, INC.S Sale	Director, President and CEO	SSale	−1,817 sh	$104.55	−$190K	241,558
2026-09-14	RYTMRHYTHM PHARMACEUTICALS, INC.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+50K sh	$6.05	+$303K	289,258
2026-09-14	RYTMRHYTHM PHARMACEUTICALS, INC.S Sale	Director, President and CEO	SSale	−30.7K sh	$102.35	−$3.15M	252,073
2026-06-17	KARDKardigan, Inc.A Award	Director	AAward	+20.7K sh	—	—	20,706
2026-06-03	TRVITrevi Therapeutics, Inc. · Nonstatutory Stock Option (right to buy)A Award	Director	AAward	+35K sh	—	—	35,000
2026-02-11	RYTMRHYTHM PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	Director, President and CEO	AAward	+71.9K sh	—	—	71,900
2026-02-11	RYTMRHYTHM PHARMACEUTICALS, INC. · Stock Options (Right to Buy)A Award	Director, President and CEO	AAward	+108K sh	—	—	107,850
2026-02-01	RYTMRHYTHM PHARMACEUTICALS, INC.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+68.7K sh	—	—	270,538
2026-02-01	RYTMRHYTHM PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−33.3K sh	—	—	100,012
2026-02-01	RYTMRHYTHM PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−21.3K sh	—	—	42,500
2026-02-01	RYTMRHYTHM PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−14.1K sh	—	—	14,125
2026-02-01	RYTMRHYTHM PHARMACEUTICALS, INC.F Tax Payment	Director, President and CEO	FTax Payment	−31.5K sh	$108.99	−$3.44M	239,016
2025-06-11	TRVITrevi Therapeutics, Inc. · Nonstatutory Stock Option (right to buy)A Award	Director	AAward	+45K sh	—	—	45,000
2025-06-03	RYTMRHYTHM PHARMACEUTICALS, INC.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+43.6K sh	$4.59	+$200K	245,445
2025-06-03	RYTMRHYTHM PHARMACEUTICALS, INC.S Sale	Director, President and CEO	SSale	−274 sh	$65.60	−$18K	201,825
2025-06-03	RYTMRHYTHM PHARMACEUTICALS, INC.S Sale	Director, President and CEO	SSale	−43.3K sh	$65.04	−$2.82M	202,099
2025-06-03	RYTMRHYTHM PHARMACEUTICALS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−43.6K sh	—	—	0
2025-02-19	RYTMRHYTHM PHARMACEUTICALS, INC.S Sale	Director, President and CEO	SSale	−9,896 sh	$57.22	−$566K	201,281
2025-02-16	RYTMRHYTHM PHARMACEUTICALS, INC.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+21.3K sh	—	—	211,177
2025-02-16	RYTMRHYTHM PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−21.3K sh	—	—	63,750
2025-02-14	RYTMRHYTHM PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	Director, President and CEO	AAward	+133K sh	—	—	133,350
2025-02-14	RYTMRHYTHM PHARMACEUTICALS, INC. · Stock Options (Right to Buy)A Award	Director, President and CEO	AAward	+200K sh	—	—	200,000
2025-02-04	RYTMRHYTHM PHARMACEUTICALS, INC.S Sale	Director, President and CEO	SSale	−4,278 sh	$59.43	−$254K	189,927
2025-02-01	RYTMRHYTHM PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−14.1K sh	—	—	28,250
2025-02-01	RYTMRHYTHM PHARMACEUTICALS, INC.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+14.1K sh	—	—	194,205
2024-08-27	TRVITrevi Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−4,555 sh	—	—	0
2024-08-27	TRVITrevi Therapeutics, Inc.S Sale	Director	SSale	−4,555 sh	$2.93	−$13.4K	352,489
2024-08-27	TRVITrevi Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+4,555 sh	$1.43	+$6,513.65	357,044
2024-06-13	TRVITrevi Therapeutics, Inc. · Nonstatutory Stock Option (right to buy)A Award	Director	AAward	+30K sh	—	—	30,000
2024-03-19	RYTMRHYTHM PHARMACEUTICALS, INC.S Sale	Director, President and CEO	SSale	−45.5K sh	$39.22	−$1.78M	174,605
2024-02-16	RYTMRHYTHM PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+259K sh	—	—	259,000
2024-02-16	RYTMRHYTHM PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	Director, President and CEO	AAward	+85K sh	—	—	85,000
2024-02-16	RYTMRHYTHM PHARMACEUTICALS, INC.A Award	Director, President and CEO	AAward	+99K sh	—	—	220,099
2024-02-01	RYTMRHYTHM PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−14.1K sh	—	—	42,375
2024-02-01	RYTMRHYTHM PHARMACEUTICALS, INC.S Sale	Director, President and CEO	SSale	−4,361 sh	$45.06	−$197K	121,099
2024-02-01	RYTMRHYTHM PHARMACEUTICALS, INC.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+14.1K sh	—	—	125,460
2023-06-28	TRVITrevi Therapeutics, Inc. · Nonstatutory Stock Option (right to buy)A Award	Director	AAward	+30K sh	—	—	30,000
2023-02-01	RYTMRHYTHM PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	Director, President and CEO	AAward	+56.5K sh	—	—	56,500
2023-02-01	RYTMRHYTHM PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+230K sh	—	—	229,600
2022-06-23	TRVITrevi Therapeutics, Inc. · Nonstatutory Stock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2022-06-23	TRVITrevi Therapeutics, Inc. · Nonstatutory Stock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2022-02-09	RYTMRHYTHM PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+510K sh	—	—	510,000
2021-06-16	TRVITrevi Therapeutics, Inc. · Nonstatutory Stock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2021-03-30	RYTMRHYTHM PHARMACEUTICALS, INC.P Purchase	Director, President and CEO	PPurchase	+10K sh	$20.17	+$202K	111,335
2021-02-11	RYTMRHYTHM PHARMACEUTICALS, INC. · Stock Option (right to buy)A Award	Director, President and CEO	AAward	+220K sh	—	—	220,000
2020-11-17	MyoKardia, Inc.Stock Option (Right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−3,000 sh	—	—	0

Recent filings

Accepted (ET)
Sep 144
Meeker David P0001649904-26-000026
SEC(opens sec.gov)
Jun 224
Meeker David P0001193125-26-277950
SEC(opens sec.gov)
Jun 44
Meeker David P0001193125-26-257373
SEC(opens sec.gov)
Feb 134
Meeker David P0001104659-26-015403
SEC(opens sec.gov)
Feb 34
Meeker David P0001104659-26-009768
SEC(opens sec.gov)
Jun 134
Meeker David P0000950170-25-086109
SEC(opens sec.gov)
Jun 54
Meeker David P0001104659-25-056838
SEC(opens sec.gov)

Companies

Address

C/O RHYTHM PHARMACEUTICALS, INC. 222 BERKELEY STREET, 12TH FLOOR

BOSTON, MA, 02116